AAAAAA

   
Results: 1-25 | 26-39
Results: 1-25/39

Authors: GUEDON C BORG JY LALAUDE O LECAMDUCHEZ V PHILIPPE C LEREBOURS E COLIN R
Citation: C. Guedon et al., ENHANCED PROCOAGULANT ACTIVITY IN ACUTE CROHNS-DISEASE (CD), Gastroenterology, 114(4), 1998, pp. 4052-4052

Authors: LEVESQUE H BORG JY COURTOIS H
Citation: H. Levesque et al., THE VASCULAR RISK OF 3RD-GENERATION ORAL- CONTRACEPTIVES, Journal des maladies vasculaires, 22(1), 1997, pp. 5-12

Authors: BORG JY YASTREMSKY F DESHAYES A TOULLEC J CHRETIEN MH VASSE M SALADINTHIRON C FREBOURG T
Citation: Jy. Borg et al., RELIABLE IDENTIFICATION OF FACTOR-V-LEIDEN INDIVIDUALS BY MODIFIED APC RESISTANCE TESTS, Thrombosis and haemostasis, 1997, pp. 82-82

Authors: LECAMDUCHEZ V GANDRILLE S ALHENCGELAS M EMMERICH J BORG JY AIACH M
Citation: V. Lecamduchez et al., ADDITIONAL GENETIC RISK-FACTORS FOR THROMBOSIS IN 21 FAMILIES CARRYING THE FACTOR-V ARG-506 TO GLN MUTATION, Thrombosis and haemostasis, 1997, pp. 671-671

Authors: BORG JY DURIEZ D THIRION C NICHAM F PERRY DJ CARRELL RW
Citation: Jy. Borg et al., IMPROVEMENT IN THE IDENTIFICATION OF ANTITHROMBIN DEFICIENT PATIENTS, Thrombosis and haemostasis, 1997, pp. 1768-1768

Authors: POUPLARD C AMIRAL J BORG JY VISSAC AM DELAHOUSSE B REVERDIAUMOALIC P GRUEL Y
Citation: C. Pouplard et al., DIFFERENCES IN SPECIFICITY OF HEPARIN-DEPENDENT ANTIBODIES DEVELOPED DURING LOW-MOLECULAR-WEIGHT-HEPARIN THERAPY AND HIGHER CROSS-REACTIVITY WITH ORGARAN, Thrombosis and haemostasis, 1997, pp. 1826-1826

Authors: AILLAUD MF JUHAN I BAUTERS A JUDE B BIRON C SCHVED JF PERNOD G POLACK B DELAHOUSSE B FIMBEL B MARQUESVERDIER A BRIDEY F TRUCHAUD F TROSSAERT M BIHOUR C VERGNES C GRIS JC DENNINGER MH DUTRILLAUX F LORENZINI JL HOUBOUYAN L LEQUERREC A FREYBURGER G BORG JY BOINOT C SULTAN Y TREZIACK MC BERRUYER M GUERIN V TOULON P MASSIGNON D DESCHAMPS A FAVIER R ROBERT A JULIA A
Citation: Mf. Aillaud et al., CLINICAL AND BIOLOGICAL DATA IN 68 SUBJECTS WITH HOMOZYGOUS R506Q MUTATION - FRENCH REGISTER ON ACTIVATED PROTEIN-C RESISTANCE (APCR) - PROCARE STUDY, Thrombosis and haemostasis, 1997, pp. 2368-2368

Authors: BORG JY LEVESQUE H CAILLEUX N FRANC C HELLOT MF COURTOIS H
Citation: Jy. Borg et al., RAPID QUANTITATIVE D-DIMER ASSAY AND CLINICAL-EVALUATION FOR THE DIAGNOSIS OF CLINICALLY SUSPECTED DEEP-VEIN THROMBOSIS, Thrombosis and haemostasis, 77(3), 1997, pp. 602-603

Authors: GOUDEMAND J CARON C DEPROST D DERLON A BORG JY SAMPOL J SIE P
Citation: J. Goudemand et al., EVALUATION OF SENSITIVITY AND SPECIFICITY OF A STANDARDIZED PROCEDUREUSING DIFFERENT REAGENTS FOR THE DETECTION OF LUPUS ANTICOAGULANTS, Thrombosis and haemostasis, 77(2), 1997, pp. 336-342

Authors: POUPLARD C AMIRAL J BORG JY VISSAC AM DELAHOUSSE B GRUEL Y
Citation: C. Pouplard et al., DIFFERENCES IN SPECIFICITY OF HEPARIN-DEPENDENT ANTIBODIES DEVELOPED IN HEPARIN-INDUCED THROMBOCYTOPENIA AND CONSEQUENCES ON CROSS-REACTIVITY WITH DANAPAROID SODIUM, British Journal of Haematology, 99(2), 1997, pp. 273-280

Authors: ALHENCGELAS M LECAMDUCHEZ V EMMERICH J FREBOURG T FIESSINGER JN BORG JY AIACH M
Citation: M. Alhencgelas et al., THE A20210-ALLELE OF THE PROTHROMBIN GENE IS NOT FREQUENTLY ASSOCIATED WITH THE FACTOR-V-ARG-506-TO-GLN-MUTATION IN THROMBOPHILIC FAMILIES, Blood, 90(4), 1997, pp. 1711-1711

Authors: BIRON C SCHVED JF AILLAUD MF JUHAN I BAUTERS A JUDE B PERNOD G POLACK B BRIDEY F DEPROST D BORG JY SALADIN C LECAM V DENNINGER MH TRUCHAUD F TROSSAERT M BOINOT C SULTAN Y DELAHOUSSE B FIMBEL B GRUEL Y HOUBOUYAN L BIHOUR C VERGNES C DUTRILLAUX F LORENZINI JL JULIA A DESCHAMPS A FAVIER R FREYBURGER G TREZIACK MC BERRUYER M GRIS JC TOULON P MARQUESVERDIER A LEQUERREC A GUERIN V MASSIGNON D
Citation: C. Biron et al., CLINICAL AND BIOLOGICAL DATA IN 85-R506Q HOMOZYGOTES - FRENCH REGISTER ON ACTIVATED PROTEIN-C RESISTANCE (APCR) - PROCARE STUDY, Blood, 90(10), 1997, pp. 654-654

Authors: MARIE I LEVESQUE H HERON F CAILLEUX N BORG JY COURTOIS H
Citation: I. Marie et al., ACUTE ADRENAL FAILURE SECONDARY TO BILATERAL INFARCTION OF THE ADRENAL-GLANDS AS THE FIRST MANIFESTATION OF PRIMARY ANTIPHOSPHOLIPID ANTIBODY SYNDROME, Annals of the Rheumatic Diseases, 56(9), 1997, pp. 567-568

Authors: SCHLEIFER DM CHASSAING S CARON F BORG JY BOUCHART F SOYER R
Citation: Dm. Schleifer et al., CALCIUM HEPARIN-INDUCED HYPEREOSINOPHILIA, La Presse medicale, 25(37), 1996, pp. 1848-1848

Authors: BOUANICHE M GUEDON C BORG JY ZALAR A DUCROTTE P LEREBOURS E
Citation: M. Bouaniche et al., ANTIPHOSPHOLIPID SYNDROME AS A CAUSE OF P ORTAL-VEIN THROMBOSIS - 2 CASES, Gastroenterologie clinique et biologique, 20(10), 1996, pp. 897-900

Authors: CAILLEUX N LEVESQUE H COURTOIS H BORG JY
Citation: N. Cailleux et al., ACQUIRED ANTI-VIII ANTIBODIES - A NEW CAS E, Journal des maladies vasculaires, 21(5), 1996, pp. 324-328

Authors: CAILLEUX N GUEGANMASSARDIER E BORG JY VASSE M MIHOUT B WATELET J LEVESQUE H COURTOIS H
Citation: N. Cailleux et al., PSEUDOTHROMBOANGIITIS OBLITERANS AND QUAL ITATIVE PROTEIN-C DEFECT - A CASE-REPORT, Journal des maladies vasculaires, 21(1), 1996, pp. 47-49

Authors: DUCHEMIN J BORG JY BORGEL D VASSE M LEVEQUE H AIACH M GANDRILLE S
Citation: J. Duchemin et al., 5 NOVEL MUTATIONS OF THE PROTEIN-S ACTIVE GENE (PROS-1) IN 8 NORMAN FAMILIES, Thrombosis and haemostasis, 75(3), 1996, pp. 437-444

Authors: BORG JY MARTEL P KERLEAU JM LEFEBVRE H WOLF LM
Citation: Jy. Borg et al., ASSOCIATION OF PRIMARY ANTIPHOSPHOLIPID S YNDROME AND ANTITHROMBIN-III DEFICIENCY IN A PATIENT WITH CEREBRAL INFARCTION - A FIRST CASE, La Revue de medecine interne, 17(12), 1996, pp. 1044-1045

Authors: MATHONNET F DEMAZANCOURT P BASTENAIRE B MOROT M BENATTAR N BEUFE S BORG JY GIUDICELLI Y
Citation: F. Mathonnet et al., ACTIVATED PROTEIN-C SENSITIVITY RATIO IN PREGNANT-WOMEN AT DELIVERY, British Journal of Haematology, 92(1), 1996, pp. 244-246

Authors: BIRON C SCHVED HF AILLAUD MF JUHAN I BAUTERS A JUDE B PERNOD G POLACK B DELAHOUSSE B FIMBEL B MARQUESVERDIER A BRIDEY F TRUCHAUD F TROSSAERT M BIHOUR C VERGNES C GRIS JC DENNINGER MH DUTRILLAUX F LORENZINI JL HOUBOUYAN L LEQUERREC A FREYBURGER G BORG JY BOINOT C SULTAN Y TREZIACK MC BERURRIER M GUERIN V TOULON P MASSIGNON D DESCHAMPS A FAVIER R JULIA A
Citation: C. Biron et al., FRENCH REGISTER ON ACTIVATED PROTEIN-C RESISTANCE (APCR) - THE PROCARE STUDY, Blood, 88(10), 1996, pp. 685-685

Authors: BORG JY
Citation: Jy. Borg, CAN LOW-MOLECULAR-WEIGHT HEPARIN BE USED IN PREGNANT-WOMEN, Annales de medecine interne, 147, 1996, pp. 45-47

Authors: PERRY DJ MARSHALL C BORG JY TAIT RC DALY ME WALKER ID CARRELL RW
Citation: Dj. Perry et al., 2 NOVEL ANTITHROMBIN VARIANTS, ASN187ASP AND ASN187LYS, INDICATE A FUNCTIONAL-ROLE FOR ASPARAGINE 187, Blood coagulation & fibrinolysis, 6(1), 1995, pp. 51-54

Authors: VASSE M GAUCHER C BEUFE S VANDREDEN P MONCONDUIT M MAZURIER C BORG JY SORIA C
Citation: M. Vasse et al., ANALYSIS OF FACTOR-VIII IN A FAMILY WITH INHERITED RESISTANCE TO ACTIVATED PROTEIN-C WITHOUT FACTOR-V LEYDEN, Thrombosis and haemostasis, 73(6), 1995, pp. 1369-1369

Authors: VOISIN L DERUMEAUX G BORG JY MEJJAD O VITTECOQ O TAYOT J THOMINE E TRON F LELOET X
Citation: L. Voisin et al., CATASTROPHIC ANTIPHOSPHOLIPID SYNDROME WITH FATAL ACUTE COURSE IN RHEUMATOID-ARTHRITIS, Journal of rheumatology, 22(8), 1995, pp. 1586-1588
Risultati: 1-25 | 26-39